Stock Screener App

Frei -

Installieren

3.145

2.02% -0.065

Lantern Pharma Inc (LTRN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Lantern Pharma Inc-Aktie (LTRN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	17.52% 5.732	4.8774	3.5236	5.1903	4.2863
Operating Income/Loss	17.52% -5.732	-4.8774	-3.5236	-5.1903	-4.2863
Income/Loss From Continuing Operations Before Tax	29.98% -5.4408	-4.1859	-3.1615	-4.7464	-3.8678
Income/Loss From Continuing Operations After Tax	29.98% -5.4408	-4.1859	-3.1615	-4.7464	-3.8678
Net Income/Loss	29.98% -5.4408	-4.1859	-3.1615	-4.7464	-3.8678
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	72,760% 10.74	-0.0148	10.86	10.86	10.86
Diluted Average Shares	72,760% 10.74	-0.0148	10.86	10.86	-
Basic Earnings Per Share	30.77% -0.51	-0.39	-0.29	-0.44	-0.36
Diluted Earnings Per Share	30.77% -0.51	-0.39	-0.29	-0.44	-0.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters